A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England

Kent Yip

doi:10.1016/s0169-5002(17)30112-5

A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England

Kent Yip

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Lung Cancer
DOIs	https://doi.org/10.1016/s0169-5002(17)30112-5
Publication status	Published - 1 Jan 2017
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0169-5002(17)30112-5

Cite this

@article{a31e14987c0a427da84a142d4dc8c3fc,

title = "A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England",

author = "Kent Yip",

year = "2017",

month = jan,

day = "1",

doi = "10.1016/s0169-5002(17)30112-5",

language = "English",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier",

}

TY - JOUR

T1 - A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England

AU - Yip, Kent

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://dx.doi.org/10.1016/s0169-5002(17)30112-5

U2 - 10.1016/s0169-5002(17)30112-5

DO - 10.1016/s0169-5002(17)30112-5

M3 - Article

SN - 0169-5002

JO - Lung Cancer

JF - Lung Cancer

ER -